SFM
Sphera Funds Management’s Astria Therapeutics ATXS Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $1.38M | Buy |
257,402
+67,602
| +36% | +$362K | 0.32% | 69 |
|
2025
Q1 | $1.01M | Buy |
189,800
+50,000
| +36% | +$267K | 0.23% | 87 |
|
2024
Q4 | $1.25M | Buy |
139,800
+3,218
| +2% | +$28.8K | 0.23% | 86 |
|
2024
Q3 | $1.5M | Sell |
136,582
-26,260
| -16% | -$289K | 0.24% | 87 |
|
2024
Q2 | $1.48M | Buy |
162,842
+50,000
| +44% | +$455K | 0.2% | 88 |
|
2024
Q1 | $1.59M | Sell |
112,842
-1,038,303
| -90% | -$14.6M | 0.22% | 79 |
|
2023
Q4 | $8.84M | Buy |
1,151,145
+570,546
| +98% | +$4.38M | 1.42% | 21 |
|
2023
Q3 | $4.33M | Buy |
580,599
+109,581
| +23% | +$817K | 0.79% | 41 |
|
2023
Q2 | $3.92M | Buy |
471,018
+50,000
| +12% | +$417K | 0.61% | 49 |
|
2023
Q1 | $5.6M | Sell |
421,018
-48,322
| -10% | -$643K | 0.94% | 34 |
|
2022
Q4 | $6.99M | Buy |
+469,340
| New | +$6.99M | 1.5% | 16 |
|
2021
Q2 | – | Sell |
-1,294,000
| Closed | -$3.74M | – | 123 |
|
2021
Q1 | $3.74M | Buy |
+1,294,000
| New | +$3.74M | 0.29% | 76 |
|
2018
Q1 | – | Sell |
-328,030
| Closed | -$489K | – | 108 |
|
2017
Q4 | $489K | Buy |
328,030
+40,000
| +14% | +$59.6K | 0.06% | 114 |
|
2017
Q3 | $611K | Hold |
288,030
| – | – | 0.09% | 100 |
|
2017
Q2 | $409K | Sell |
288,030
-100,000
| -26% | -$142K | 0.07% | 103 |
|
2017
Q1 | $621K | Buy |
388,030
+87
| +0% | +$139 | 0.12% | 92 |
|
2016
Q4 | $1.4M | Hold |
387,943
| – | – | 0.35% | 68 |
|
2016
Q3 | $2.39M | Buy |
387,943
+184,700
| +91% | +$1.14M | 0.39% | 61 |
|
2016
Q2 | $752K | Sell |
203,243
-26,798
| -12% | -$99.2K | 0.2% | 76 |
|
2016
Q1 | $1.16M | Buy |
230,041
+149,299
| +185% | +$752K | 0.25% | 72 |
|
2015
Q4 | $640K | Sell |
80,742
-246,734
| -75% | -$1.96M | 0.09% | 106 |
|
2015
Q3 | $2.6M | Sell |
327,476
-118,560
| -27% | -$939K | 0.33% | 65 |
|
2015
Q2 | $5.06M | Buy |
+446,036
| New | +$5.06M | 0.5% | 36 |
|